Human chorionic gonadotropin β Complete Research Guide (2026)
Last updated 2026-06-30
TL;DR
Human chorionic gonadotropin (also known as hCG) is a peptide catalogued under Sexual Health (Placental). Documented context: Infertility; cryptorchidism. Neutral reference entry; EU status: EU-approved prescription medicine.
What is Human chorionic gonadotropin?
Human chorionic gonadotropin (hCG) is a placental glycoprotein hormone that acts on the LH receptor.
It is an approved medicine for hypogonadotropic hypogonadism, prepubertal cryptorchidism, and ovulation induction in assisted reproduction, and it has a large clinical evidence base.
Importantly, the FDA has long held that hCG is not effective for weight loss, and the hCG diet is not supported by controlled evidence.
How does Human chorionic gonadotropin work?
hCG mimics luteinizing hormone, stimulating testicular Leydig cells to produce testosterone and supporting intratesticular androgen levels and spermatogenesis in men.
In women it triggers final follicular maturation and ovulation.
What does the research say about Human chorionic gonadotropin?
- hCG can maintain or restore spermatogenesis and intratesticular testosterone in hypogonadotropic hypogonadism. [1]
- Adding concurrent hCG helps preserve spermatogenesis in men on testosterone replacement therapy. [2]
- hCG is used as an option to manage secondary hypogonadism and support male fertility. [3]
Clinical research & studies
The references below are the primary sources cited throughout this guide. Each links directly to PubMed or the regulator. Where evidence is preclinical (animal or in-vitro), that is stated rather than implied.
- [1] Maintenance of spermatogenesis in hypogonadotropic hypogonadal men with human chorionic gonadotropin alone β Depenbusch M et al., European Journal of Endocrinology 2002. (Clinical study)
- [2] Concomitant intramuscular human chorionic gonadotropin preserves spermatogenesis in men undergoing testosterone replacement therapy β Hsieh TC et al., The Journal of Urology 2013. (Clinical cohort)
- [3] Human chorionic gonadotropin treatment: a viable option for management of secondary hypogonadism and male infertility β Fink J et al., Expert Review of Endocrinology and Metabolism 2021. (Review)
- [4] Addition of recombinant follicle-stimulating hormone to human chorionic gonadotropin treatment in adolescents and young adults with hypogonadotropic hypogonadism promotes normal testicular growth and may promote early spermatogenesis β Zacharin M et al., Fertility and Sterility 2012. (Clinical study)
- [5] Ineffectiveness of human chorionic gonadotropin in weight reduction: a double-blind study β Stein MR et al., The American Journal of Clinical Nutrition 1976. (Randomized double-blind trial)
- [6] Human chorionic gonadotrophin and weight loss. A double-blind, placebo-controlled trial β Bosch B et al., South African Medical Journal 1990. (Randomized double-blind placebo-controlled trial)
Dosing context
In clinical practice hCG is given by injection, with regimens differing widely by indication, for example intermittent dosing to stimulate testosterone and spermatogenesis versus a single trigger dose in fertility cycles.
These descriptions are context only and not dosing instructions; regimens must be set by a clinician.
Side effects & safety profile
hCG is a prescription hormone; reported effects include injection-site reactions, gynecomastia, mood changes, and, in ovulation induction, ovarian hyperstimulation syndrome and multiple pregnancy.
It should be used only under medical supervision.
hCG is NOT proven effective for weight loss: multiple double-blind, placebo-controlled trials found no benefit over placebo, and very-low-calorie hCG diets carry their own risks.
Stacking & combinations
In male-fertility protocols hCG is often combined with FSH (or hMG) to drive both androgen production and complete spermatogenesis.
Finding Human chorionic gonadotropin vendors
Finding Human chorionic gonadotropin vendors
This is an independent, neutral directory β we sell nothing and route no purchases. Use it to read regulatory context and (where available) genuine, moderated vendor information for your country.
Choose your country
We never list placeholder vendors. Pick your country to see neutral regulatory context.
User reviews
No reviews yet
Reviews appear here once submitted and moderated. An aggregate rating is shown only after at least 5 genuine reviews β we never fabricate ratings.
Frequently asked questions
Approved uses include hypogonadotropic hypogonadism and prepubertal cryptorchidism in males, and ovulation induction and final oocyte maturation in assisted reproduction. Exact labeling varies by country.
References
- [1] Maintenance of spermatogenesis in hypogonadotropic hypogonadal men with human chorionic gonadotropin alone β Depenbusch M et al., European Journal of Endocrinology 2002. PMID: 12444893. View sourceStudy: Clinical studyhCG monotherapy maintained spermatogenesis in men whose sperm production had first been initiated by combined gonadotropins.
- [2] Concomitant intramuscular human chorionic gonadotropin preserves spermatogenesis in men undergoing testosterone replacement therapy β Hsieh TC et al., The Journal of Urology 2013. PMID: 23260550. View sourceStudy: Clinical cohortLow-dose hCG alongside testosterone therapy preserved semen parameters in the majority of men.
- [3] Human chorionic gonadotropin treatment: a viable option for management of secondary hypogonadism and male infertility β Fink J et al., Expert Review of Endocrinology and Metabolism 2021. PMID: 33345656. View sourceStudy: ReviewReviews hCG as a treatment to raise testosterone and support fertility in secondary hypogonadism.
- [4] Addition of recombinant follicle-stimulating hormone to human chorionic gonadotropin treatment in adolescents and young adults with hypogonadotropic hypogonadism promotes normal testicular growth and may promote early spermatogenesis β Zacharin M et al., Fertility and Sterility 2012. PMID: 22763096. View sourceStudy: Clinical studyhCG plus rFSH promoted testicular growth and early spermatogenesis in young hypogonadotropic males.
- [5] Ineffectiveness of human chorionic gonadotropin in weight reduction: a double-blind study β Stein MR et al., The American Journal of Clinical Nutrition 1976. PMID: 786001. View sourceStudy: Randomized double-blind trialhCG was no better than placebo for weight loss, hunger, or well-being on a calorie-restricted diet.
- [6] Human chorionic gonadotrophin and weight loss. A double-blind, placebo-controlled trial β Bosch B et al., South African Medical Journal 1990. PMID: 2405506. View sourceStudy: Randomized double-blind placebo-controlled trialhCG produced no significant advantage over placebo for weight loss or fat distribution.